0001752724-24-132302.txt : 20240613 0001752724-24-132302.hdr.sgml : 20240613 20240613142306 ACCESSION NUMBER: 0001752724-24-132302 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240613 DATE AS OF CHANGE: 20240613 EFFECTIVENESS DATE: 20240613 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MUTUAL FUND SERIES TRUST CENTRAL INDEX KEY: 0001355064 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: OH FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-21872 FILM NUMBER: 241040836 BUSINESS ADDRESS: STREET 1: C/O GEMINI FUND SERVICES LLC STREET 2: 4221 NORTH 203RD STREET, SUITE 100 CITY: ELKHORN STATE: NE ZIP: 68022-3474 BUSINESS PHONE: 631 549 1859 MAIL ADDRESS: STREET 1: C/O GEMINI FUND SERVICES LLC STREET 2: 4221 NORTH 203RD STREET, SUITE 100 CITY: ELKHORN STATE: NE ZIP: 68022-3474 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST FUNDS DATE OF NAME CHANGE: 20060303 0001355064 S000048680 AlphaCentric Income Opportunities Fund C000153405 AlphaCentric Income Opportunities Fund Class A IOFAX C000153406 AlphaCentric Income Opportunities Fund Class C IOFCX C000153407 AlphaCentric Income Opportunities Fund Class I IOFIX 0001355064 S000055006 AlphaCentric Premium Opportunity Fund C000173003 AlphaCentric Premium Opportunity Fund Class A HMXAX C000173004 AlphaCentric Premium Opportunity Fund Class C HMXCX C000173005 AlphaCentric Premium Opportunity Fund Class I HMXIX 0001355064 S000057714 AlphaCentric Robotics and Automation Fund C000186116 AlphaCentric Robotics and Automation Fund Class A GNXAX C000186117 AlphaCentric Robotics and Automation Fund Class C GNXCX C000186118 AlphaCentric Robotics and Automation Fund Class I GNXIX 0001355064 S000066020 AlphaCentric Symmetry Strategy Fund C000213450 AlphaCentric Symmetry Strategy Fund Class I SYMIX C000213451 AlphaCentric Symmetry Strategy Fund Class A SYMAX C000213452 AlphaCentric Symmetry Strategy Fund Class C SYMCX 0001355064 S000067055 AlphaCentric LifeSci Healthcare Fund C000215729 AlphaCentric LifeSci Healthcare Fund Class C LYFCX C000215730 AlphaCentric LifeSci Healthcare Fund Class I LYFIX C000215731 AlphaCentric LifeSci Healthcare Fund Class A LYFAX 0001355064 S000071674 AlphaCentric Strategic Income Fund C000227116 AlphaCentric Strategic Income Fund Class I SIIIX C000227117 AlphaCentric Strategic Income Fund Class A SIIAX C000227118 AlphaCentric Strategic Income Fund Class C SIICX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001355064 XXXXXXXX 811-21872 N-1A S000057714 C000186116 C000186118 C000186117 S000067055 true S000071674 true S000055006 C000173003 C000173005 C000173004 S000066020 true S000048680 C000153405 C000153406 C000153407 Mutual Fund Series Trust 811-21872 0001355064 5493002ZGLQMLR4QMA96 4221 NORTH 203RD STREET, SUITE 100 Elkhorn 68022-3474 US-NE US 631-549-1859 Ultimus Fund Solutions, LLC 225 Pictoria Drive, Suite 450 Cincinnati 45246 631-470-2600 Records related to its function as administrator, accounting agent and transfer agent N N N-1A 35 Y Stephen P. Lachenauer N/A N Tiberiu Weisz N/A N Jerry Szilagyi N/A Y Tobias Caldwell N/A N Frederick J. Schmidt N/A 36 N. New York Avenue Huntington 11743 XXXXXX N N N N N N Northern Lights Distributors LLC 8-65857 000126159 N/A Y N Cohen & Company 925 N/A N Y N N N N AlphaCentric Robotics and Automation Fund S000057714 549300E21ZG78LC2JI72 N 3 0 0 N/A N N Y N N U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N N/A 6631117.45166666 219614.00000000 Rule 32a-4 (17 CFR 270.32a-4) Y Y Y N AlphaCentric Advisors LLC 801-79616 000170679 N/A N Contego Capital Group, Inc. 801-113844 000128518 N/A N N Ultimus Fund Solutions, LLC 84-05829 N/A N N N ICE Data Services 5493000NQ9LYLDBCTL34 N/A N N U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N Ultimus Fund Solutions, LLC 84-05829 Filing Number N N N Ultimus Fund Solutions, LLC 84-06083 Filing Number N N N BTIG, LLC 8-65473 000122225 549300GTG9PL6WO3EC51 74994.47000000 74994.47000000 BTIG, LLC 8-65473 000122225 549300GTG9PL6WO3EC51 1602906.32000000 1602906.32000000 N 28990162.52319672 Uncommitted 100000000.00000000 N N N AlphaCentric LifeSci Healthcare Fund S000067055 549300XV4TMPQ6UX8179 N 3 0 0 N/A N N N N N/A N/A N/A Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4)) Rule 32a-4 (17 CFR 270.32a-4) Y Y Y N AlphaCentric Advisors LLC 801-79616 000170679 N/A N LifeSci Fund Management LLC 801-117201 000305001 N/A N N Ultimus Fund Solutions, LLC 84-05829 N/A N N N ICE Data Services 5493000NQ9LYLDBCTL34 N/A N N U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N Ultimus Fund Solutions, LLC 84-05829 Filing Number N N N Ultimus Fund Solutions, LLC 84-06083 Filing Number N N N SVB Leerink LLC 8-48535 000039011 549300AAH7U76CEUBI94 28209.53000000 Jonestrading Institutional Services LLC 8-26089 000006888 2138008JJ5PA8H5UIL69 750.00000000 William Blair & Company, L.L.C 8-2698 000001252 549300J0P7XYE8BMZ775 9827.10000000 BTIG, LLC 8-65473 000122225 549300GTG9PL6WO3EC51 38611.78000000 Jefferies Group 8-15074 000002347 58PU97L1C0WSRCWADL48 94328.05000000 RBC Capital Markets, LLC 8-45411 000031194 549300LCO2FLSSVFFR64 18261.33000000 R.J. O'Brien Securities, LLC 8-67587 000143624 549300Y3W4512F4J2D08 35962.17000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 450.54000000 Oppenheimer & Co. Inc 8-4077 000000249 254900VH02JQR2L8XD64 46815.59000000 273216.09000000 Jefferies Group 8-15074 000002347 58PU97L1C0WSRCWADL48 965749.72000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 1890000.00000000 William Blair & Company, L.L.C 8-2698 000001252 549300J0P7XYE8BMZ775 72500.00000000 Goldman Sachs & Co LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 126000.00000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 115500.00000000 SVB Leerink LLC 8-48535 000039011 549300AAH7U76CEUBI94 3234750.00000000 6404499.71999999 N 99329190.57633882 Uncommitted 100000000.00000000 N N N N AlphaCentric Strategic Income Fund S000071674 549300YDYHXBQRIQH163 N 3 0 0 N/A N N N N N/A N/A N/A Rule 32a-4 (17 CFR 270.32a-4) Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4)) Y Y Y N AlphaCentric Advisors LLC 801-79616 000170679 N/A N Goshen Rock Capital, LLC 801-120776 000313546 N/A N N Ultimus Fund Solutions, LLC 84-05829 N/A N N N ICE Data Services 5493000NQ9LYLDBCTL34 N/A N N U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N Ultimus Fund Solutions, LLC 84-05829 Filing Number N N N Ultimus Fund Solutions, LLC 84-06083 Filing Number N N N Jonestrading Institutional Services LLC 8-26089 000006888 2138008JJ5PA8H5UIL69 283.50000000 BTIG, LLC 8-65473 000122225 549300GTG9PL6WO3EC51 862.35000000 Cantor Fitzgerald & Co. 8-201 000000134 5493004J7H4GCPG6OB62 12639.47000000 Odeon Capital Group LLC 8-68033 000148493 549300S158163H2DN048 12.54000000 13797.86000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 1255003.85055080 Bmo Capital Markets Corp. 8-34344 000016686 RUC0QBLBRPRCU4W1NE59 3347516.47605208 Performance Trust Capital Partners, LLC 8-47035 000036155 549300F8NR5Q23JRIY74 3206454.65635343 Stephens Inc. 8-1927 000003496 213800LH6T9XDYZCA534 1526643.97970714 Goldman Sachs & Co LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 4659050.00000000 Browstone Investment Group LLC 8-50460 000043884 549300EBC8OHVQMGF416 1146681.32005960 Odeon Capital Group LLC 8-68033 000148493 549300S158163H2DN048 2798832.80776745 BTIG, LLC 8-65473 000122225 549300GTG9PL6WO3EC51 1500106.20099600 Seaport Global Securities LLC 8-53535 000116270 54930028D6D0G5RZJ888 4221712.77094045 Wells Fargo Securities, LLC 8-65876 000126292 VYVVCKR63DVZZN70PB21 1360806.15014000 25022808.21256697 N 55813009.70710378 Uncommitted 100000000.00000000 N N N AlphaCentric Premium Opportunity Fund S000055006 54930050MG8D4Y1NZE85 N 3 0 0 N/A N N N N N/A N/A N/A Rule 32a-4 (17 CFR 270.32a-4) Rule 18f-4 (17 CFR 270.18f-4) Y Y Y N AlphaCentric Advisors LLC 801-79616 000170679 N/A N Ultimus Fund Solutions, LLC 84-05829 N/A N N N ICE Data Services 5493000NQ9LYLDBCTL34 N/A N N U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N Ultimus Fund Solutions, LLC 84-05829 Filing Number N N N Ultimus Fund Solutions, LLC 84-06083 Filing Number N N N Interactive Brokers 8-47257 000036418 50OBSE5T5521O6SMZR28 53452.84000000 53452.84000000 STONEX FINANCIAL INC 8-51269 000045993 549300LNKU6K5TJCRG93 69996898.64374999 U.S. Bancorp Investments, Inc. 8-35359 000017868 H85Z6XZP8B10ES0M2G89 14529694.69999999 84526593.34375000 N 81564632.27620220 Uncommitted 100000000.00000000 N N N N AlphaCentric Symmetry Strategy Fund S000066020 549300KS6XKZRXD32T67 N 3 0 0 N/A Y N N N/A N/A N/A Rule 18f-4 (17 CFR 270.18f-4) Rule 32a-4 (17 CFR 270.32a-4) Y Y Y N AlphaCentric Advisors LLC 801-79616 000170679 N/A N Mount Lucas Management LP 801-28254 000108255 549300KGSSFB18TBWK88 N N Ultimus Fund Solutions, LLC 84-05829 N/A N N N ICE Data Services 5493000NQ9LYLDBCTL34 N/A N N U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N Ultimus Fund Solutions, LLC 84-05829 Filing Number N N N Ultimus Fund Solutions, LLC 84-06083 Filing Number N N N RBC Capital Markets, LLC 8-45411 000031194 549300LCO2FLSSVFFR64 1719.69000000 SG Americas Securities, LLC 8-66125 000128351 549300F35UE0BOM1WJ55 13364.24000000 15083.93000000 SG Americas Securities, LLC 8-66125 000128351 549300F35UE0BOM1WJ55 71024685.22785100 71024685.22785100 N 43537468.49568305 Uncommitted 100000000.00000000 N N N AlphaCentric Income Opportunity Fund S000048680 549300G5GDKQ1HGLKQ58 N 3 0 0 N/A N N N N N/A N/A N/A Rule 32a-4 (17 CFR 270.32a-4) Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4)) Y Y Y N AlphaCentric Advisors LLC 801-79616 000170679 N/A N Garrison Point Capital, LLC 801-77191 000165590 254900DD7OOGDOE3TP64 N N Ultimus Fund Solutions, LLC 84-05829 N/A N N N ICE Data Services 5493000NQ9LYLDBCTL34 N/A N Pricing Direct 549300WIC0TOJ7N7GD54 N/A N N U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N Ultimus Fund Solutions, LLC 84-05829 Filing Number N N N Ultimus Fund Solutions, LLC 84-06083 Filing Number N N N 0.00 Piper Sandler & Co. 8-15204 000000665 549300GRQCWQ3XGH0H10 57602218.06652957 Brean Capital, LLC 8-40742 000023723 254900ZZA1UBVDCNQ378 48200857.40589024 Mesirow Financial, Inc. 8-28816 000002764 549300BIV46SUHPOFE54 8397767.19757499 Bmo Capital Markets Corp. 8-34344 000016686 RUC0QBLBRPRCU4W1NE59 27216873.66471250 CitiGroup Inc. 8-8177 000007059 6SHGI4ZSSLCXXQSBB395 380850747.94853956 BTIG, LLC 8-65473 000122225 549300GTG9PL6WO3EC51 27680143.21664229 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 21891241.40625000 Browstone Investment Group LLC 8-50460 000043884 549300EBC8OHVQMGF416 183192501.79609323 Odeon Capital Group LLC 8-68033 000148493 549300S158163H2DN048 49510519.18984872 SG Americas Securities, LLC 8-66125 000128351 549300F35UE0BOM1WJ55 9091040.75110444 813633910.64318562 N 454006468.55401659 Uncommitted 100000000.00000000 N N N true true LEGAL PROCEEDINGS 2 Income_Legal_Proceeding.txt INCOME LEGAL PROCEEDING AlphaCentric Income Opportunities Fund LEGAL PROCEEDINGS On July 30, 2020, an investor in the AlphaCentric Income Opportunities Fund (the "Fund") filed a putative class action in Florida state court, naming AlphaCentric Advisors LLC, Mutual Fund Series Trust, and others as defendants. Plaintiff alleges that the Fund misrepresented that it held no more than 15% of its assets in illiquid securities, among other things, and asserts violations of Sections 11, 12(a)(2) and 15 of the Securities Act of 1933. On October 14, 2020, the same Plaintiff filed a nearly identical putative class action in New York State Court against the same defendants. That complaint was amended on February 26, 2021, which added two additional defendants, including sub-advisor Garrison Point LLC. On February 22, 2021, defendants moved to dismiss the Florida action for lack of personal jurisdiction. On May 20, 2020, defendants moved to dismiss the New York action for failure to allege any material misrepresentations or omissions, among other things. We believe these lawsuits are meritless and intend to contest them vigorously. INTERNAL CONTROL RPT 3 Internal_Control_Letter.txt ALPHACENTRIC FUNDS IC LETTER 3.31.2024 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders of AlphaCentric Income Opportunities Fund, AlphaCentric Premium Opportunity Fund, AlphaCentric Robotics and Automation Fund, AlphaCentric Symmetry Strategy Fund, AlphaCentric LifeSci Healthcare Fund, and AlphaCentric Strategic Income Fund and Board of Trustees of Mutual Fund Series Trust In planning and performing our audit of the financial statements of AlphaCentric Income Opportunities Fund, AlphaCentric Premium Opportunity Fund, AlphaCentric Robotics and Automation Fund, AlphaCentric LifeSci Healthcare Fund, AlphaCentric Strategic Income Fund and the consolidated financial statements of AlphaCentric Symmetry Strategy Fund (the "Funds"), each a series of Mutual Fund Series Trust, as of and for the year ended March 31, 2024, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Funds internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds internal control over financial reporting. Accordingly, we express no such opinion. The management of the Funds is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A funds internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles (GAAP). A funds internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a funds assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Funds annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Funds internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted a deficiency in the Funds internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of March 31, 2024. Due to system limitations, the accretion of discount on an investment in a deeply discounted security had to be tracked and recorded manually in an offline schedule. Controls did not allow for the capture of all the trading activity in the offline schedule for this security, resulting in a material adjustment to the recorded accretion. We believe this represents a material weakness in internal control over financial reporting. This report is intended solely for the information and use of management and the Board of Trustees of the Funds and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. /s/ COHEN & COMPANY, LTD. Philadelphia, Pennsylvania May 30, 2024